Mostrando 478,441 - 478,460 Resultados de 481,023 Para Buscar '"academic"', tiempo de consulta: 2.52s Limitar resultados
  1. 478441
  2. 478442
  3. 478443
  4. 478444
  5. 478445
  6. 478446
  7. 478447
  8. 478448
    “…We evaluated whether musculoskeletal (total and regional lean body mass [LBM] and bone mineral density [BMD]) outcomes were different in PCOS (n=126) across 4 prospectively recruited groups matched for age, body mass index, waist to hip ratio, and lack of recent (<3 mos) hormonal contraceptive and metformin use: self-identified (1) White (n=86); (2) Black (n=17); (3) Asian (n=12); and, (4) Hispanic (n=11) women in 3 academic medical centers in NY. PCOS was defined by the Rotterdam criteria using the recommended thresholds of the most recent (2018) PCOS Guideline. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 478449
  10. 478450
    “…Similar disparities were observed when comparing industry-funded and academic center–sponsored trials. CONCLUSIONS AND RELEVANCE: In this cross-sectional study of participants in phase 1 clinical trials of drugs for metastatic cancer, worsening disparities were observed over time in the accrual of patients from racial and ethnic minority groups. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 478451
    “…DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included patients aged 18 years or older with newly diagnosed nonmetastatic OPC who received curative-intent radiotherapy with IMPT or IMRT at a single-institution tertiary academic cancer center from January 1, 2018, to December 31, 2021, with follow-up through December 31, 2021. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 478452
  13. 478453
    “…Methods: We included 200 outpatients with HMs and predominantly lymphoid neoplasms (96%, 191/200) in our academic center and reported on the humoral responses, which were assessed by measurement of anti-spike IgG antibodies in peripheral blood as early as 14 days after mRNA-based prime-boost vaccination, as well as factors hampering booster efficacy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 478454
  15. 478455
  16. 478456
  17. 478457
  18. 478458
  19. 478459
  20. 478460
Herramientas de búsqueda: RSS